Guidelines for the diagnosis and management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017

Critical Care Medicine

Volumn 45, Issue 12, 2017, Pages 2078-2088

  Annane, Djillali ^a   Pastores, Stephen M ^b   Rochwerg, Bram ^c   Arlt, Wiebke ^d   Balk, Robert A ^e   Beishuizen, Albertus ^f   Briegel, Josef ^g   Carcillo, Joseph ^h   Christ Crain, Mirjam ⁱ   Cooper, Mark S ^j   Marik, Paul E ^k   Meduri, Gianfranco Umberto ^l   Olsen, Keith M ^m   Rodgers, Sophia C ⁿ   Russell, James A ^o   Van Den Berghe, Greet ^p  

^a Raymond Poincaré Hospital APHP   (France)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e RUSH UNIVERSITY   (United States)

^f MEDISCH SPECTRUM TWENTE   (Netherlands)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^j UNIVERSITY OF SYDNEY   (Australia)

^k EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

ⁿ UNIVERSITY OF NEW MEXICO   (United States)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

Acute respiratory distress syndrome; Corticosteroids; Critical illness; Glucocorticoids; Major trauma; Sepsis; Septic shock

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; ADULT RESPIRATORY DISTRESS SYNDROME; ADVISORY COMMITTEE; BLOOD; CRITICAL ILLNESS; HUMAN; INJURY; INTENSIVE CARE; PRACTICE GUIDELINE; SEPSIS; SEPTIC SHOCK; SEVERITY OF ILLNESS INDEX; STANDARDS;

ADRENAL CORTEX HORMONES; ADRENAL INSUFFICIENCY; ADVISORY COMMITTEES; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYDROCORTISONE; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; WOUNDS AND INJURIES;

EID: 85039556703     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002737     Document Type: Article

References (66)

1. Marik PE, Pastores SM, Annane D, et al: American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36(6):1937-1949
2. Cochrane Collaboration: Cochrane: Review Manager. Edition 5.2. Edited by Centre TNC. Copenhagen, Denmark, Cochrane Collaboration, 2012
3. Shea BJ, Grimshaw JM, Wells GA, et al: Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7:10
4. Higgins JP, Altman DG, Gøtzsche PC, et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:d5928
5. Wells GA, Shea B, O'Connell D, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Available at: www.ohri.ca/programs/clinical-epidemiology/ oxford.asp. Accessed November 21, 2016
6. Whiting P, Rutjes AW, Reitsma JB, et al: The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3:25
7. Kavanagh BP: The GRADE system for rating clinical guidelines. PLoS Med 2009; 6:e1000094
8. Andrews JC, Schünemann HJ, Oxman AD, et al: GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol 2013; 66:726-735
9. Rhodes A, Evans LE, Alhazzani W, et al: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017 Mar; 43(3):304-377
10. Bornstein SR, Allolio B, Arlt W, et al: Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101(2):364-389
11. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003; 31(1): 141-145
12. de Jong MF, Molenaar N, Beishuizen A, et al: Erratum to: Diminished adrenal sensitivity to endogenous and exogenous adrenocorticotropic hormone in critical illness: A prospective cohort study. Crit Care 2015; 19:313
13. Yang Y, Liu L, Jiang D, et al: Critical illness-related corticosteroid insufficiency after multiple traumas: A multicenter, prospective cohort study. J Trauma Acute Care Surg 2014; 76:1390-1396
14. Menon K, Ward RE, Lawson ML, et al; Canadian Critical Care Trials Group: A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 2010; 182:246-251
15. Hamrahian AH, Oseni TS, Arafah BM: Measurements of serum free cortisol in critically ill patients. N Engl J Med 2004; 350:1629-1638
16. Molenaar N, Johan Groeneveld AB, Dijstelbloem HM, et al: Assessing adrenal insufficiency of corticosteroid secretion using free versus total cortisol levels in critical illness. Intensive Care Med 2011; 37:1986-1993
17. Tarjányi Z, Montskó G, Kenyeres P, et al: Free and total cortisol levels are useful prognostic markers in critically ill patients: A prospective observational study. Eur J Endocrinol 2014; 171:751-759
18. Jessop DS, Turner-Cobb JM: Measurement and meaning of salivary cortisol: A focus on health and disease in children. Stress 2008; 11:1-14
19. Galbois A, Obadia E, Chalumeau-Lemoine L, et al: Using serum total cortisol assays overstates the adrenal insufficiency prevalence in cirrhotic patients. Eur Rev Med Pharmacol Sci 2016; 20:3730-3731
20. Galbois A, Rudler M, Massard J, et al: Assessment of adrenal function in cirrhotic patients: Salivary cortisol should be preferred. J Hepatol 2010; 52:839-845
21. Estrada-Y-Martin RM, Orlander PR: Salivary cortisol can replace free serum cortisol measurements in patients with septic shock. Chest 2011; 140(5):1216-1222
22. Coolens JL, Van Baelen H, Heyns W: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 1987; 26:197-202
23. Ho JT, Al-Musalhi H, Chapman MJ, et al: Septic shock and sepsis: A comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006; 91:105-114
24. Ospina NS, Al Nofal A, Bancos I, et al: ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2016; 101:427-434
25. Moraes RB, Friedman G, Tonietto T, et al: Comparison of low and high dose cosyntropin stimulation tests in the diagnosis of adrenal insufficiency in septic shock patients. Horm Metab Res 2012; 44:296-301
26. Schneider AJ, Voerman HJ: Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids. Intensive Care Med 1991; 17:436-437
27. Baldwin WA, Allo M: Occult hypoadrenalism in critically ill patients. Arch Surg 1993; 128:673-676
28. Annane D, Bellissant E, Sebille V, et al: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998; 46:589-597
29. Marik PE, Zaloga GP: Adrenal insufficiency during septic shock. Crit Care Med 2003;31:141-145
30. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
31. Arabi YM, Aljumah A, Dabbagh O, et al: Low-dose hydrocortisone in patients with cirrhosis and septic shock: A randomized controlled trial. CMAJ 2010; 182:1971-1977
32. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
33. Keh D, Trips E, Marx G, et al; SepNet-Critical Care Trials Group: Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial. JAMA 2016; 316:1775-1785
34. Wira CR, Dodge K, Sather J, Dziura J: Meta-analysis of protocolized goal-directed hemodynamic optimization for the management of severe sepsis and septic shock in the Emergency Department. West J Emerg Med 2014; 15:51-59
35. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y: Corticosteroids for treating sepsis. Cochrane Database Syst Rev 2015; 12:CD002243
36. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29(7):1303-1310
37. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348(16): 1546-1554
38. Torio CM, Andrews RM: National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb. 2013 Aug
39. Fleischmann C, Thomas-Rueddel DO, Hartmann M, et al: Hospital incidence and mortality rates of sepsis. Dtsch Arztebl Int 2016; 113(10):159-166
40. Annane D, Bellisant E, Cavaillon JM: Septic shock. Lancet 2005; 365(9453):63-78
41. Prigent H, Maxime V, Annane D: Clinical review: Corticotherapy in sepsis. Crit Care 2004; 8(2):122-129
42. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y: Corticosteroids for treating sepsis. Cochrane Database Syst Rev 2015; 12:CD002243
43. Gibbison B, López-López JA, Higgins JP, Miller T, Angelini GD, Lightman SL, Annane D: Corticosteroids in septic shock: A systematic review and network meta-analysis. Crit Care 2017; 21(1):78
44. O'Hearn K, McNally D, Choong K, et al; Canadian Critical Care Trials Group: Steroids in fluid and/or vasoactive infusion dependent pediatric shock: Study protocol for a randomized controlled trial. Trials 2016; 17:238
45. Menon K, McNally D, O'Hearn K, et al; Canadian Critical Care Trials Group: A Randomized Controlled Trial of Corticosteroids in Pediatric Septic Shock: A Pilot Feasibility Study. Pediatr Crit Care Med 2017; 18:505-512
46. Tongyoo S, Permpikul C, Mongkolpun W, et al: Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: Results of a randomized controlled trial. Crit Care 2016; 20:329
47. El-Nawawy A, Khater D, Omar H, et al: Evaluation of Early Corticosteroid Therapy in Management of Pediatric Septic Shock in Pediatric Intensive Care Patients: A Randomized Clinical Study. Pediatr Infect Dis J 2017; 36:155-159
48. Annane D, Buisson CB, Cariou A, et al; APROCCHSS Investigators for the TRIGGERSEP Network: Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial. Ann Intensive Care 2016; 6:43
49. Ranieri VM, Thompson BT, Barie PS, et al: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2013; 366(22):2055-2064
50. Venkatesh B, Myburgh J, Finfer S, et al: The ADRENAL study protocol: Adjunctive corticosteroid treatment in critically ill patients with septic shock. Crit Care Resusc 2013; 15(2):83-88
51. Bellani G, Laffey JG, Pham T, et al; LUNG SAFE Investigators; ESICM Trials Group: Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 2016; 315:788-800
52. Angus DC, Clermont G, Linde-Zwirble WT, et al; NO-06 Investigators: Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med 2006; 34:2883-2890
53. Hill AD, Fowler RA, Burns KE, et al: Long-Term Outcomes and Health Care Utilization after Prolonged Mechanical Ventilation. Ann Am Thorac Soc 2017; 14:355-362
54. Herridge MS, Chu LM, Matte A, et al; RECOVER Program Investigators (Phase 1: Towards RECOVER); Canadian Critical Care Trials Group: The RECOVER Program: Disability Risk Groups and 1-Year Outcome after 7 or More Days of Mechanical Ventilation. Am J Respir Crit Care Med 2016; 194:831-844
55. Meduri GU, Headley AS, Golden E, et al: Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: A randomized controlled trial. JAMA 1998; 280:159-165
56. Steinberg KP, Hudson LD, Goodman RB, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network: Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006; 354:1671-1684
57. Meduri GU, Golden E, Freire AX, et al: Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial. Chest 2007; 131(4):954-963
58. Rezk NA, Ibrahim AM: Effects of methylprednisolone in early ARDS. Egyptian J Chest Dis & Tuberc 2013; 6291:167-172
59. Confalonieri M, Urbino R, Potena A, et al: Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study. Am J Respir Crit Care Med 2005; 171:242-248
60. Annane D, Sébille V, Bellissant E; Ger-Inf-05 Study Group: Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006; 34:22-30
61. Meduri GU, Bridges L, Shih MC, et al: Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 2016; 42:829-840
62. Meduri GU, Eltorky MA: Understanding ARDS-associated fibroproliferation. Intensive Care Medicine 2015; 41(3): 517-520
63. Greos LS, Vichyanond P, Bloedow DC, et al: Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis. Am Rev Respir Dis 1991; 144:586-592
64. Hoen S, Asehnoune K, Brailly-Tabard S, et al: Cortisol response to corticotropin stimulation in trauma patients: Influence of hemorrhagic shock. Anesthesiology 2002; 97:807-813
65. Roquilly A, Mahe PJ, Seguin P, et al: Hydrocortisone therapy for patients with multiple trauma: The randomized controlled HYPOLYTE study. JAMA 2011; 305:1201-1209
66. Asehnoune K, Seguin P, Allary J, et al; Corti-TC Study Group: Hydrocortisone and fludrocortisone for prevention of hospital-acquired pneumonia in patients with severe traumatic brain injury (Corti-TC): A double-blind, multicentre phase 3, randomised placebo-controlled trial. Lancet Respir Med 2014; 2:706-716